In January 2018, during the Executive budget address, Governor Cuomo directed the Department of Health (DOH) to review the health, criminal justice and economic impacts of regulating recreational marijuana in New York. ...more
7/25/2018
/ Compassionate Use Act ,
Decriminalization of Marijuana ,
Department of Health and Human Services (HHS) ,
Federal v State Law Application ,
Marijuana ,
Marijuana Related Businesses ,
Medical Marijuana ,
Pain Management ,
Regulatory Agenda ,
Regulatory Oversight ,
State and Local Government
Our series highlighting recent activity by the NYS Legislature continues with a recap of bills passed in 2018 that relate to behavioral health. This synopsis follows previous summaries we have done concerning pharmacy,...more
7/6/2018
/ Continuing Education ,
Disabilities ,
Elder Issues ,
Health Care Providers ,
Home Health Care ,
Hospitals ,
Legislative Agendas ,
Medical Marijuana ,
Mental Health ,
Proposed Legislation ,
Regulatory Oversight ,
State and Local Government ,
Substance Abuse ,
Suicide
During a year in which legislative activity was restrained by a variety of factors, most notably the Senate’s inability to maintain a consistent majority, the New York State Legislature nonetheless still passed 641 bills,...more
6/27/2018
/ Biologics ,
Controlled Substances ,
Cosmetics ,
Decriminalization of Marijuana ,
Legislative Agendas ,
Manufacturers ,
Medical Devices ,
Medical Marijuana ,
Pain Management ,
Personal Care Products ,
Pesticides ,
Pharmaceutical Industry ,
Prescription Drugs ,
Proposed Legislation ,
Reclassification Rules ,
Regulatory Oversight ,
Regulatory Requirements ,
Risk Assessment ,
Risk Mitigation ,
State and Local Government
Several provisions in the recently adopted 2018-19 New York State Budget (the “Enacted Budget”) are intended to address the ongoing opioid crisis. As discussed in a prior post, some were focused on pharmaceutical...more
4/9/2018
/ Drug & Alcohol Abuse ,
Drug Treatment ,
Healthcare Facilities ,
Mental Health ,
Opioid ,
Outpatient Services ,
Pain Management ,
Prescription Drugs ,
Regulatory Oversight ,
State and Local Government ,
State Budgets ,
State Funding ,
Substance Abuse
Notwithstanding the enactment of a first-in-the-nation drug spending cap last year, in light of the $4.4 billion deficit and ongoing concerns about the opioid crisis it was inevitable that this year New York State would once...more
4/5/2018
/ Drug Distribution ,
Drug Pricing ,
Generic Drugs ,
Opioid ,
Pain Management ,
Pharmaceutical Industry ,
Pharmacies ,
Prescription Drugs ,
Rebates ,
Regulatory Oversight ,
State and Local Government ,
State Budgets ,
State Medicaid Programs